What are the contraindications to initiating cholesterol‑lowering therapy (e.g., statins)?

Contraindications to Statin Therapy

The primary contraindications to initiating statin therapy are cholestasis and active liver disease, though even these are not absolute contraindications based on available evidence. 12

Formal Contraindications

The ACC/AHA/NHLBI guidelines explicitly list only two conditions as contraindications 12:

• Cholestasis
• Active liver disease

Critical Caveat About These "Contraindications"

Importantly, no specific evidence exists showing that statins actually exacerbate liver disease 12. In fact:

• Statins have not been shown to worsen outcomes in patients with chronic transaminase elevations from hepatitis B or C
• Treatment of hyperlipidemia may actually improve transaminase elevations in individuals with fatty liver 12
• Progression to liver failure specifically due to statins is exceedingly rare if it ever occurs 12

This means that even the listed contraindications should be interpreted cautiously in clinical practice, as the evidence supporting them is weak.

Relative Contraindications and High-Risk Situations

While not absolute contraindications, exercise extreme caution or avoid statins in these scenarios:

Pregnancy

• Not explicitly mentioned in the provided guidelines but standard practice contraindication

High-Risk Drug Combinations

The combination of statins with certain medications significantly increases myopathy risk 12:

• Gemfibrozil (particularly dangerous - associated with 12 of 31 deaths from cerivastatin-related rhabdomyolysis)
• Cyclosporine
• Macrolide antibiotics
• Certain antifungal drugs
• Niacin (when combined with statins)

These interactions often involve the cytochrome P-450 3A4 isozyme 12.

Complex Medical Situations

Myositis is most likely in patients who have 12:

• Complex medical problems
• Multiple concurrent medications
• Renal impairment (risk of rhabdomyolysis with myoglobinuria and acute renal necrosis)

What Are NOT Contraindications

Do not withhold statins for these conditions 12:

• Chronic hepatitis B or C with elevated transaminases
• Fatty liver disease
• Mild transaminase elevations (0.5-2% of patients develop these; they're dose-dependent and often reversible with dose reduction)
• History of muscle aches alone without CK elevation (occurs in ~5% of both placebo and statin groups in trials)

Practical Algorithm for Initiation

1. Screen for absolute contraindications: Active cholestasis or severe active liver disease
2. Review medication list: Identify dangerous drug interactions (especially gemfibrozil, cyclosporine, macrolides, azole antifungals)
3. Assess complexity: Multiple comorbidities + polypharmacy = higher myopathy risk
4. If concerns exist but statin needed: Start low dose, monitor closely, consider alternative statins with different metabolism pathways

The key principle: statins are remarkably safe drugs, and the cardiovascular benefits considerably outweigh potential risks in the vast majority of patients 3. True absolute contraindications are extremely limited.